201 related articles for article (PubMed ID: 30972713)
1. Increased coagulation factor XIII activity but not genetic variants of coagulation factors is associated with myocardial infarction in young patients.
Ambroziak M; Kuryłowicz A; Budaj A
J Thromb Thrombolysis; 2019 Oct; 48(3):519-527. PubMed ID: 30972713
[TBL] [Abstract][Full Text] [Related]
2. Association of genetic variants of hemostatic genes with myocardial infarction in Egyptian patients.
El-Fattah AAA; Sadik NAH; Sedrak H; Battah A; Nabil M
Gene; 2018 Jan; 641():212-219. PubMed ID: 29054763
[TBL] [Abstract][Full Text] [Related]
3. Factor XIII Val34Leu polymorphism and the risk of myocardial infarction under the age of 36 years.
Rallidis LS; Politou M; Komporozos C; Panagiotakos DB; Belessi CI; Travlou A; Lekakis J; Kremastinos DT
Thromb Haemost; 2008 Jun; 99(6):1085-9. PubMed ID: 18521512
[TBL] [Abstract][Full Text] [Related]
4. Factor XIII val34leu and the risk of myocardial infarction.
Franco RF; Pazin-Filho A; Tavella MH; Simões MV; Marin-Neto JA; Zago MA
Haematologica; 2000 Jan; 85(1):67-71. PubMed ID: 10629595
[TBL] [Abstract][Full Text] [Related]
5. Effect of factor XIII levels and polymorphisms on the risk of myocardial infarction in young patients.
Balogh L; Katona É; Mezei ZA; Kállai J; Gindele R; Édes I; Muszbek L; Papp Z; Bereczky Z
Mol Cell Biochem; 2018 Nov; 448(1-2):199-209. PubMed ID: 29484525
[TBL] [Abstract][Full Text] [Related]
6. The association between factor XIII Val34Leu polymorphism and early myocardial infarction.
Hancer VS; Diz-Kucukkaya R; Bilge AK; Ozben B; Oncul A; Ergen G; Nalcaci M
Circ J; 2006 Mar; 70(3):239-42. PubMed ID: 16501286
[TBL] [Abstract][Full Text] [Related]
7. Decreased factor XIII levels in factor XIII A subunit Leu34 homozygous patients with coronary artery disease.
Bereczky Z; Balogh E; Katona E; Czuriga I; Kárpáti L; Shemirani AH; Edes I; Muszbek L
Thromb Res; 2008; 121(4):469-76. PubMed ID: 17597187
[TBL] [Abstract][Full Text] [Related]
8. Coagulation F13A1 V34L, fibrinogen and homocysteine versus conventional risk factors in the pathogenesis of MI in young persons.
Vishwajeet V; Jamwal M; Sharma P; Das R; Ahluwalia J; Dogra RK; Rohit MK
Acta Cardiol; 2018 Aug; 73(4):328-334. PubMed ID: 28978253
[TBL] [Abstract][Full Text] [Related]
9. Epistatic and pleiotropic effects of polymorphisms in the fibrinogen and coagulation factor XIII genes on plasma fibrinogen concentration, fibrin gel structure and risk of myocardial infarction.
Mannila MN; Eriksson P; Ericsson CG; Hamsten A; Silveira A
Thromb Haemost; 2006 Mar; 95(3):420-7. PubMed ID: 16525568
[TBL] [Abstract][Full Text] [Related]
10. Factor XIII Val34Leu polymorphism and recurrent myocardial infarction in patients with coronary artery disease.
Kreutz RP; Bitar A; Owens J; Desta Z; Breall JA; von der Lohe E; Sinha A; Vatta M; Nystrom P; Jin Y; Flockhart DA
J Thromb Thrombolysis; 2014 Oct; 38(3):380-7. PubMed ID: 24510702
[TBL] [Abstract][Full Text] [Related]
11. Adiponectin gene variants and decreased adiponectin plasma levels are associated with the risk of myocardial infarction in young age.
Ambroziak M; Kolanowska M; Bartoszewicz Z; Budaj A
Gene; 2018 Feb; 642():498-504. PubMed ID: 29196254
[TBL] [Abstract][Full Text] [Related]
12. Association of factor XIII Val34Leu polymorphism and coronary artery disease: A meta-analysis.
Jung JH; Song GG; Kim JH; Seo YH; Choi SJ
Cardiol J; 2017; 24(1):74-84. PubMed ID: 27665853
[TBL] [Abstract][Full Text] [Related]
13. Association of FXIII Val34Leu with decreased risk of myocardial infarction in Finnish males.
Wartiovaara U; Perola M; Mikkola H; Tötterman K; Savolainen V; Penttilä A; Grant PJ; Tikkanen MJ; Vartiainen E; Karhunen PJ; Peltonen L; Palotie A
Atherosclerosis; 1999 Feb; 142(2):295-300. PubMed ID: 10030380
[TBL] [Abstract][Full Text] [Related]
14. Factor XIIIA-V34L and factor XIIIB-H95R gene variants: effects on survival in myocardial infarction patients.
Gemmati D; Federici F; Campo G; Tognazzo S; Serino ML; De Mattei M; Valgimigli M; Malagutti P; Guardigli G; Ferraresi P; Bernardi F; Ferrari R; Scapoli GL; Catozzi L
Mol Med; 2007; 13(1-2):112-20. PubMed ID: 17515963
[TBL] [Abstract][Full Text] [Related]
15. Genetic variants of coagulation factor XIII, postmenopausal estrogen therapy, and risk of nonfatal myocardial infarction.
Reiner AP; Heckbert SR; Vos HL; Ariëns RA; Lemaitre RN; Smith NL; Lumley T; Rea TD; Hindorff LA; Schellenbaum GD; Rosendaal FR; Siscovick DS; Psaty BM
Blood; 2003 Jul; 102(1):25-30. PubMed ID: 12456499
[TBL] [Abstract][Full Text] [Related]
16. A common mutation in the gene for coagulation factor XIII-A (VAL34Leu): a risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases.
Gemmati D; Serino ML; Ongaro A; Tognazzo S; Moratelli S; Resca R; Moretti M; Scapoli GL
Am J Hematol; 2001 Jul; 67(3):183-8. PubMed ID: 11391716
[TBL] [Abstract][Full Text] [Related]
17. An association study of thrombospondin 1 and 2 SNPs with coronary artery disease and myocardial infarction among South Indians.
Ashokkumar M; Anbarasan C; Saibabu R; Kuram S; Raman SC; Cherian KM
Thromb Res; 2011 Oct; 128(4):e49-53. PubMed ID: 21762961
[TBL] [Abstract][Full Text] [Related]
18. Coagulation factor XIII-A Val34Leu polymorphism and the risk of coronary artery disease and myocardial infarction in a Chinese Han population.
Guodong Jin ; Beili Feng ; Peng Chen ; Oushan Tang ; Jian Wang ; Ji Ma ; Yuping Shi ; Geng Xu
Clin Appl Thromb Hemost; 2011 Apr; 17(2):208-13. PubMed ID: 20211923
[TBL] [Abstract][Full Text] [Related]
19. The association between fibrinogen haplotypes and myocardial infarction in men is partly mediated through pleiotropic effects on the serum IL-6 concentration.
Mannila MN; Eriksson P; Leander K; Wiman B; de Faire U; Hamsten A; Silveira A
J Intern Med; 2007 Feb; 261(2):138-47. PubMed ID: 17241179
[TBL] [Abstract][Full Text] [Related]
20. A common F13A1 intron 1 variant IVS1+12(A) is associated with mild FXIII deficiency in Caucasian population.
Ivaskevicius V; Biswas A; Thomas A; Lyonga S; Rott H; Halimeh S; Kappert G; Klammroth R; Scholz U; Eberl W; Harbrecht U; Gnida C; Hertfelder HJ; Marquardt N; Oldenburg J
Ann Hematol; 2013 Jul; 92(7):975-9. PubMed ID: 23508224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
